What is the current Price Target for the Unicycive Therapeutics Inc stock?

The average Unicycive Therapeutics Inc target price is $7.42. This is 1,157.06% higher than the current stock price. The highest price target is 1,594.92%, the lowest is 408.47%. 6 Analysts have issued a price target Unicycive Therapeutics Inc 2026 .

How high will the Unicycive Therapeutics Inc stock rise?

No reliable answer can be given as to how high the Unicycive Therapeutics Inc stock will rise. The performance of stocks, including the Unicycive Therapeutics Inc stock, depends on a variety of factors, such as the general economic situation, the company's business results, investor expectations and global events.

What's going on with the Unicycive Therapeutics Inc stock today?

The performance of Unicycive Therapeutics Inc stock on any given day can be influenced by various factors, such as market conditions, industry trends, company news and global events.

Why did the Unicycive Therapeutics Inc stock fall?

The decline in Unicycive Therapeutics Inc stock may be due to a variety of factors, such as market conditions, industry trends, company news, macroeconomic events or changes in investor expectations. It is important to note that stock markets are inherently volatile and the performance of an individual stock on any given day is not necessarily indicative of its long-term performance.

What is a price target?

A price target is an estimate by an analyst or investment bank of where a company's stock price could be in a certain period of time, usually 12 months.

Unicycive Therapeutics Inc Forecast, price target & analysts

$0.52

12.08% today

Nasdaq, Apr 04, 09:17 pm CET

ISIN

US90466Y1038

Symbol

UNCY

Reports

Quarter | Annual

Index

NASDAQ Composite

Sector

Services

Industry

Various services

Overview Dividends Analysts Charts News Strategies

Unicycive Therapeutics Inc Target price 2025 - Analyst rating & recommendation

Unicycive Therapeutics Inc Classifications & Recommendation:

Buy

100%

Unicycive Therapeutics Inc Price Target

Target Price	$7.42
Price	$0.59
Potential	1,157.06% register free of charge
Number of Estimates	6

	6 Analysts have issued a price target Unicycive Therapeutics Inc 2026 . The average Unicycive Therapeutics Inc target price is $7.42. This is 1,157.06% register free of charge higher than the current stock price. The highest price target is $10.00 1,594.92% register free of charge , the lowest is $3.00 408.47% register free of charge .
	A rating was issued by 6 analysts: 6 Analysts recommend Unicycive Therapeutics Inc to buy, 0 to hold and 0 to sell.
	Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
	Analyst Estimates: Analysts believe that the Unicycive Therapeutics Inc stock has an average upside potential 2026 of 1,157.06% register free of charge . Most analysts recommend the Unicycive Therapeutics Inc stock at Purchase.

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2029

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually

	Dec '24	2025 Estimates
Earnings Per Share $	-0.56	-0.13
	56.25%	76.79%
P/E		negative
EV/Sales		1.58

5 Analysts have issued a Unicycive Therapeutics Inc forecast for earnings per share. The average Unicycive Therapeutics Inc EPS is

Unlock

. This is

Unlock

than earnings per share in the financial year 2024. The highest EPS forecast is

Unlock

, the lowest is

Unlock

This results in the following potential growth metrics and future valuations:

2024	$-0.56	56.25%
2025	$-0.13 76.79% Unlock
2026	$1.08 930.77% Unlock
2027	$1.50 38.89% Unlock
2028	$0.81 46.00% Unlock
2029	$0.75 7.41% Unlock

Current	-0.77	3.75%
2025	-4.61 498.70% Unlock
2026	0.55 111.93% Unlock
2027	0.39 29.09% Unlock
2028	0.73 87.18% Unlock
2029	0.79 8.22% Unlock

Unicycive Therapeutics Inc...

Current Unicycive Therapeutics Inc Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more

Analyst	Rating	Action	Date
HC Wainwright & Co.	Locked ➜ Locked	Locked	Apr 01 2025
HC Wainwright & Co.	Locked ➜ Locked	Locked	Jan 29 2025
HC Wainwright & Co.	Locked ➜ Locked	Locked	Jan 08 2025
Benchmark	Locked ➜ Locked	Locked	Nov 22 2024
HC Wainwright & Co.	Locked ➜ Locked	Locked	Nov 14 2024
HC Wainwright & Co.	Locked ➜ Locked	Locked	Nov 12 2024
HC Wainwright & Co.	Locked ➜ Locked	Locked	Oct 09 2024

Analyst Rating	Date
Locked HC Wainwright & Co.: Locked ➜ Locked	Apr 01 2025
Locked HC Wainwright & Co.: Locked ➜ Locked	Jan 29 2025
Locked HC Wainwright & Co.: Locked ➜ Locked	Jan 08 2025
Locked Benchmark: Locked ➜ Locked	Nov 22 2024
Locked HC Wainwright & Co.: Locked ➜ Locked	Nov 14 2024
Locked HC Wainwright & Co.: Locked ➜ Locked	Nov 12 2024
Locked HC Wainwright & Co.: Locked ➜ Locked	Oct 09 2024

Discover more stocks with a high price target

Novo Nordisk 83.92%

Coinbase Global, Inc. 83.53%

BioNTech SE - ADR 50.09%

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now